Uterine neoplasms, version 1.2014

Wui Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, David Cohn, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, Amanda Nickles Fader, Christine M. Fisher, David K. Gaffney, Suzanne George, Ernest Han, Warner K. Huh, John R. Lurain, Lainie Martin, David MutchSteven W. Remmenga, R. Kevin Reynolds, William Small, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Nicole McMillian, Miranda Hughes

Research output: Contribution to journalArticlepeer-review

105 Scopus citations


Adenocarcinomaof the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uterine cancer cases will occur in 2013, with 8190 deaths resulting from the disease. Uterine sarcomas (stromal/mesenchymal tumors) are uncommon malignancies, accounting for approximately 3% of all uterine cancers. The NCCN Guidelines for Uterine Neoplasms describe malignant epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management. This excerpt of these guidelines focuses on earlystage disease.

Original languageEnglish (US)
Pages (from-to)248-280
Number of pages33
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number2
StatePublished - Feb 1 2014

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Uterine neoplasms, version 1.2014'. Together they form a unique fingerprint.

Cite this